Multiple Sclerosis Trial, Recruiting (NCT07489794)

Multiple Sclerosis Trial, Recruiting NCT07489794 Sponsor: Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT07489794 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with multiple sclerosis (MS) based on specific recognised diagnostic guidelines (the 2017 McDonald criteria)
You are a woman between the ages of 30 and 50
You are experiencing urinary incontinence (leaking urine or being unable to control your bladder)
Your MS-related disability is below a certain level, meaning you are still able to walk with or without some assistance (confirm with trial site what EDSS score below 6.5 means for you)
You are able to communicate without significant difficulties

Who may not be able to join:

You do not wish to give your consent to take part in the study
You have had a change in your MS medications within the last 6 months
You are currently pregnant
You have given birth (vaginally or by caesarean section) within the last 6 months
You have a condition where one or more of your pelvic organs (such as the bladder or uterus) have dropped out of their normal position (confirm with trial site)
You currently have a urinary tract infection (a bladder or urine infection)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 905062214052

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07489794

Sponsor: Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: 905062214052

More information: https://clinicaltrials.gov/study/NCT07489794

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with multiple sclerosis (MS) based on specific recognised diagnostic guidelines (the 2017 McDonald criteria)
You are a woman between the ages of 30 and 50
You are experiencing urinary incontinence (leaking urine or being unable to control your bladder)
Your MS-related disability is below a certain level, meaning you are still able to walk with or without some assistance (confirm with trial site what EDSS score below 6.5 means for you)
You are able to communicate without significant difficulties

Who may not be able to join:

You do not wish to give your consent to take part in the study
You have had a change in your MS medications within the last 6 months
You are currently pregnant
You have given birth (vaginally or by caesarean section) within the last 6 months
You have a condition where one or more of your pelvic organs (such as the bladder or uterus) have dropped out of their normal position (confirm with trial site)
You currently have a urinary tract infection (a bladder or urine infection)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Registry

ClinicalTrials.gov

Start date

9 March 2026

Est. completion

20 September 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Pelvic floor muscle activity with surface EMG

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov